These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 28108734)

  • 1. Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression.
    Tseng JH; Chen CY; Chen PC; Hsiao SH; Fan CC; Liang YC; Chen CP
    Oncotarget; 2017 Feb; 8(9):14666-14679. PubMed ID: 28108734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines.
    Das CM; Aguilera D; Vasquez H; Prasad P; Zhang M; Wolff JE; Gopalakrishnan V
    J Neurooncol; 2007 Nov; 85(2):159-70. PubMed ID: 17534580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation.
    Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells.
    Hosein AN; Lim YC; Day B; Stringer B; Rose S; Head R; Cosgrove L; Sminia P; Fay M; Martin JH
    J Neurooncol; 2015 Apr; 122(2):263-71. PubMed ID: 25648357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation.
    Luo D; Fraga-Lauhirat M; Millings J; Ho C; Villarreal EM; Fletchinger TC; Bonfiglio JV; Mata L; Nemesure MD; Bartels LE; Wang R; Rigas B; Mackenzie GG
    Carcinogenesis; 2019 Dec; 40(12):1480-1491. PubMed ID: 30994173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synergistic effects of valproic acid and fluvastatin on apoptosis induction in glioblastoma multiforme cell lines.
    Chang YL; Huang LC; Chen YC; Wang YW; Hueng DY; Huang SM
    Int J Biochem Cell Biol; 2017 Nov; 92():155-163. PubMed ID: 29017950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dissection of the valproic acid effects on glioma cells.
    Hoja S; Schulze M; Rehli M; Proescholdt M; Herold-Mende C; Hau P; Riemenschneider MJ
    Oncotarget; 2016 Sep; 7(39):62989-63002. PubMed ID: 27556305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic modifiers as anticancer drugs: effectiveness of valproic acid in neural crest-derived tumor cells.
    Papi A; Ferreri AM; Rocchi P; Guerra F; Orlandi M
    Anticancer Res; 2010 Feb; 30(2):535-40. PubMed ID: 20332466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth.
    Lee J; Shin YJ; Lee K; Cho HJ; Sa JK; Lee SY; Kim SH; Lee J; Yoon Y; Nam DH
    Cancer Res Treat; 2018 Jul; 50(3):1009-1022. PubMed ID: 29129044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzyl isothiocyanate alters the gene expression with cell cycle regulation and cell death in human brain glioblastoma GBM 8401 cells.
    Tang NY; Chueh FS; Yu CC; Liao CL; Lin JJ; Hsia TC; Wu KC; Liu HC; Lu KW; Chung JG
    Oncol Rep; 2016 Apr; 35(4):2089-96. PubMed ID: 26781422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic targeting of glioma stem cells: Short-term and long-term treatments with valproic acid modulate DNA methylation and differentiation behavior, but not temozolomide sensitivity.
    Riva G; Butta V; Cilibrasi C; Baronchelli S; Redaelli S; Dalprà L; Lavitrano M; Bentivegna A
    Oncol Rep; 2016 May; 35(5):2811-24. PubMed ID: 26986767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo.
    Shabbeer S; Kortenhorst MS; Kachhap S; Galloway N; Rodriguez R; Carducci MA
    Prostate; 2007 Jul; 67(10):1099-110. PubMed ID: 17477369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACT001 modulates the NF-κB/MnSOD/ROS axis by targeting IKKβ to inhibit glioblastoma cell growth.
    Li Q; Sun Y; Liu B; Li J; Hao X; Ge W; Zhang X; Bao S; Gong J; Jiang Z; Qiu C; Zhao L; Zhao Y; Chen Y; Yang X; Ding Y; Wu Z
    J Mol Med (Berl); 2020 Feb; 98(2):263-277. PubMed ID: 31901951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells.
    Galanti G; Fisher T; Kventsel I; Shoham J; Gallily R; Mechoulam R; Lavie G; Amariglio N; Rechavi G; Toren A
    Acta Oncol; 2008; 47(6):1062-70. PubMed ID: 17934890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumour effect of valproic acid against salivary gland cancer in vitro and in vivo.
    Nagai H; Fujioka-Kobayashi M; Ohe G; Hara K; Takamaru N; Uchida D; Tamatani T; Fujisawa K; Miyamoto Y
    Oncol Rep; 2014 Mar; 31(3):1453-8. PubMed ID: 24398788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma.
    Ahmad F; Dixit D; Sharma V; Kumar A; Joshi SD; Sarkar C; Sen E
    Cell Death Dis; 2016 May; 7(5):e2213. PubMed ID: 27148686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA CASP5 promotes the malignant phenotypes of human glioblastoma multiforme.
    Zhou Y; Dai W; Wang H; Pan H; Wang Q
    Biochem Biophys Res Commun; 2018 Jun; 500(4):966-972. PubMed ID: 29715460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Musashi1 enhances chemotherapy resistance of pediatric glioblastoma cells in vitro.
    Pötschke R; Gielen G; Pietsch T; Kramm C; Klusmann JH; Hüttelmaier S; Kühnöl CD
    Pediatr Res; 2020 Mar; 87(4):669-676. PubMed ID: 31756732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4.
    Lan X; Lu G; Yuan C; Mao S; Jiang W; Chen Y; Jin X; Xia Q
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):177-85. PubMed ID: 26206483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase.
    Yang Y; Zhang Y; Cuevas S; Villar VA; Escano C; D Asico L; Yu P; Grandy DK; Felder RA; Armando I; Jose PA
    Free Radic Biol Med; 2012 Aug; 53(3):437-46. PubMed ID: 22634053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.